Continued vision loss from progressive expansion of inactive chorioretinal scars in a myopic patient with well-controlled sympathetic ophthalmia.

Purpose: To describe significant vision loss caused by enlargement of chorioretinal scars related to sympathetic ophthalmia despite adequate control of intraocular inflammation.

Methods: A case report of a 62-year-old man who developed sympathetic ophthalmia after a vitrectomy, which was successful in repairing a rhegmatogenous retinal detachment.

Results: Progressive expansion of chorioretinal scars occurred despite successful control of intraocular inflammation related to sympathetic ophthalmia.

Endogenous Candida albicans endophthalmitis following spontaneous abortion and IUD removal.

The authors report a rare case of a 32-year-old woman who developed endogenous Candida albicans endophthalmitis following spontaneous abortion and removal of a contraceptive intrauterine device. Considerations regarding diagnosis and management are presented based on a review of the literature.

Intraocular cysticercosis: case series and comprehensive review of the literature.

Purpose: To analyze the demographics and clinical characteristics in patients with intraocular cysticercosis.

Methods: Retrospective case series and comprehensive literature review.

Results: Intraocular cysticercosis was diagnosed in 21 of 21,079 patients (0.

Practical approach to the use of corticosteroids in patients with uveitis.

Corticosteroids constitute the first line of therapy for patients with noninfectious ocular inflammatory disease. We review factors contributing to the clinical effectiveness of various corticosteroid preparations in patients with uveitis and discuss practical aspects regarding treatment indications, when to administer various agents, and how best to dose and monitor for both treatment and adverse effects. Topically administered corticosteroids are typically indicated for the treatment of anterior uveitis, whereas periocular or intravitreal agents are employed most often in the management of intermediate or posterior intraocular inflammation.

Resolution of a giant pigment epithelial detachment after treatment with intravitreal bevacizumab.

Purpose: To describe a patient with a giant pigment epithelial detachment (PED) successfully treated with intravitreal bevacizumab.

Design: Retrospective, observational case report.

Methods: The patient's records were reviewed.